Treatment Information

Back

Brain – Glioblastoma Multiforme treatment details. Chemotherapy.

Groupe Hospitalier Pitie´Salpetriere, Paris, France.

Survival: monthsCountry:France
Toxiciy Grade:4City/State/Province:Paris
Treatments:ChemotherapyHospital:Groupe Hospitalier Pitie´Salpetriere
Drugs:Journal:Link
Date:Aug 2011

Description:

Patients:
This study involved 70 patients with newly diagnosed glioblastoma multiforme. The median age was 77 years and 40% were male.

Treatment:
Patients were treated with the chemotherapy agent temozolomide.

Toxicities:
The highest reported toxicity grade was grade 4 and included grade 3/4 neutropenia, anemia, lymphopenia, thrombocytopenia, and severe infections.

Results:
The median overall survival was 5.8 months.

Support:
Some of the authors have received support from the pharmaceutical company Schering Plough.

Correspondence: Dr. Jean-Yves Delattre; email: [email protected]



Back